Skip to main content
Tech

FDA denies Elon Musk’s request to begin brain chip trials in humans

Mar 03, 2023

Share

Neuralink, a neurotechnology company owned by Elon Musk, has claimed to have created a brain chip that treats paralysis and blindness. Musk wants to test the brain chip on patients but has faced a setback in the process. The U.S. Food and Drug Administration has denied Neuralink’s request to start human trials. According to employees who spoke with CNBC, Neuralink’s initial request to begin next steps in getting microchips on the market has been rejected.

According to the report, the FDA cited safety concerns over the chip’s lithium battery, the risk of wires migrating to other areas of the brain, and whether the device can be removed from brain tissue safely. Despite the reported setback and some skepticism surrounding the product, Musk has remained determined and optimistic on the advancements of the brain chip.

In a November presentation, Musk showed off monkeys inside the Neuralink laboratory reported to be moving computer cursors with their brains. The chip is meant to restore brain function, creating brain chip interfaces that Neuralink says could help disabled patients move and communicate again, with Musk adding it will also target restoring vision. While Musk said in his November presentation that human trials could begin in as soon as six months, given his request was denied by the FDA, he might have to reevaluate the timeline.

Tags: , , , ,

{anchor}
[karah name super]
[title: fda rejects brain chips in humans]
Elon musk is a man of many things —
Cars, rocket ships, tweeting, and brain implants.
Neuralink — owned by musk — claims to have created a brain chip that treats paralysis and blindness.
But we’re still a ways away from testing it out on patients —
After the fda denied neuralink’s request to start human trials.
{musk brain chip rejected vo}
[l3: concerns over battery, wires, removal]
According to employees who spoke with c-n-b-c —
Neuralink’s initial request to begin next steps in getting microchips on the market was rejected.
According to the report — the fda cited safety concerns over the chip’s lithium battery, the risk of wires migrating to other areas of the brain, and whether the device can be removed from brain tissue safely.
{anchor}
[l3: musk optimistic for human trials]
Despite the reported setback and some skepticism surrounding the product —
Elon musk has remained determined and optimistic on the advancements of the brain chip.
{neuralink monkeys vo}
In this november presentation — musk showed off monkeys inside the neuralink laboratory — reported to be moving computer cursors with their brains.
[l3: chip made to restore brain functions]
The chip is meant to restore brain function.
While musk said then that human trials could begin in as soon as six months —
Given today’s report — he might have to re-evaluate the timeline.